35 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• Proteostasis Therapeutics Inc PTI shares jumped 65.6 percent to $6.86 after the biopharmaceutical company that focuses on treating diseases caused by an imbalance in the proteostasis network announced an update. The company said the FDA granted a Breakthrough Therapy Designation for its PTI-428, a cystic fibrosis transmembrane conductance regulator (CFTR) amplifier.
• Bovie Medical Corporation BVX surged 20.3 percent to $2.79 following a fourth quarter earnings and sales beat.
• BlueLinx Holdings Inc. BXC shares climbed 19.1 percent to $33.38. BlueLinx shares gained 77.52 percent Monday after the company reported a $413 million merger with Cedar Creek.
• Immuron Limited IMRN rose 19 percent to $13.50 following an update regarding negotiations with a large US institutional fund.
• Innovate Biopharmaceuticals Inc INNT gained 16.2 percent to $21.87. Innovate Biopharmaceuticals named Dr. June Almenoff as COO and Chief Medical Officer.
• Zosano Pharma Corp ZSAN gained 15.92 percent to $17.84. Zosana Pharma reported a Q4 loss of $3.80 per share on Monday.
• Athersys, Inc. ATHX rose 14.7 percent to $1.79 after biotechnology company that focuses on regenerative medicine received an equity investment. The company said it received a $21 million equity investment at $1.76 per share from Healios K.K. as part of a plan to significantly expanding their existing development and commercialization collaboration.
• Northstar Realty Europe Corp NRE climbed 13.6 percent to $12.59 following Q4 results.
• Synalloy Corporation SYNL rose 9.7 percent to $15.30. Synalloy reported Q4 earnings of $0.11 per share on revenue of $52.8 million.
• Arsanis Inc ASNS shares gained 9.3 percent to $19.93.
• MediciNova, Inc. MNOV rose 9.1 percent to $14.31.
• American Vanguard Corp. AVD climbed 9 percent to $22.05. as the company posted upbeat quarterly results.
• DSW Inc. DSW shares rose 8.8 percent to $21.33. DSW reported stronger-than-expected earnings for its fourth quarter, while sales missed estimates.
• Century Aluminum Co CENX rose 8.5 percent to $22.57. Cowen & Co. upgraded Century Aluminum from Market Perform to Outperform.
• Intra-Cellular Therapies Inc ITCI shares gained 7.4 percent to $ 25.19 as the company reported 'positive' pre-NDA meeting with the FDA for lumateperone for the treatment of schizophrenia.
• Kosmos Energy Ltd KOS rose 6.1 percent to $6.24. Jefferies upgraded Kosmos Energy from Hold to Buy.
• M.D.C. Holdings, Inc. MDC gained 5.7 percent to $29.89. UBS upgraded M.D.C. from Sell to Buy.
• Cutera, Inc. CUTR gained 5.4 percent to $53.35. Stephens & Co. initiated coverage on Cutera with an Overweight rating.
• HD Supply Holdings Inc HDS rose 4.8 percent to $38.63 as the company reported better-than-expected earnings for its fourth quarter an issued a strong forecast for FY18.
• Bellicum Pharmaceuticals Inc BLCM shares gained 4.2 percent to $8.37 after the company disclosed interim results showing low rates of cancer recurrence in pediatric AML patients treated with BPX-501.

Check out these big penny stock gainers and losers

Losers

• CGG SA (ADR) CGG shares fell 27 percent to $2.08 after dropping 31.33 percent on Monday.
• Commercial Vehicle Group, Inc. CVGI shares dipped 20 percent to $8.90 after the company posted downbeat results for its fourth quarter.
• CounterPath, Corp. CPAH fell 17.5 percent to $3.82 after the company reported results for its third quarter.
• Advaxis, Inc. ADXS dipped 17.2 percent to $1.83. Advaxis reported a Q1 loss of $0.49 per share and announced a clinical hold in axalimogene filolisbac Phase 1/2 combination study with AstraZeneca's IMFINZI.
• Aralez Pharmaceuticals Inc ARLZ shares fell 14.4 percent to $1.73. Aralez reported a Q4 loss of $0.68 per share on sales of $28 million.
• Fanhua Inc (ADR) FANH dropped 14.2 percent to $27.80. Fanhua reported Q4 earnings of $0.30 per share on sales of $106.12 million.
• Tilly's Inc TLYS fell 12.3 percent to $12.58 after the company reported weaker-than-expected results for its fourth quarter. The company also issued weak first quarter guidance.
• Phoenix New Media Ltd ADR FENG dropped 10.9 percent to $5.09 following Q4 results.
• Myriad Genetics, Inc. MYGN tumbled 10.7 percent to $29.50.
• Madrigal Pharmaceuticals Inc MDGL dropped 10.6 percent to $127.76. Madrigal Pharma reported a Q4 loss of $0.67 per share.
• Vocera Communications Inc VCRA shares fell 9.9 percent to $24.57. Leerink Swann downgraded Vocera Communications from Outperform to Market Perform.
• Helios and Matheson Analytics Inc HMNY shares dipped 9.4 percent to $4.00.
• Marathon Patent Group Inc MARA declined 9.1 percent to $2.21.
• Dicks Sporting Goods Inc DKS fell 4.5 percent to $31.11. Dicks Sporting posted upbeat Q4 earnings, while sales missed expectations. The company also disclosed that it will no longer provide quarterly guidance.
• QUALCOMM, Inc. QCOM shares fell 3.4 percent to $60.67 in reaction to U.S. President Donald Trump's move to block Broadcom Ltd AVGO's proposed takeover of the U.S.-based digital communication technology company. Trump cited "credible evidence" the takeover led by the Singapore-based company "threatens to impair the national security of the US."